0001370053-20-000013.txt : 20200309 0001370053-20-000013.hdr.sgml : 20200309 20200309160545 ACCESSION NUMBER: 0001370053-20-000013 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200306 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200309 DATE AS OF CHANGE: 20200309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANAPTYSBIO, INC CENTRAL INDEX KEY: 0001370053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203828755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37985 FILM NUMBER: 20698002 BUSINESS ADDRESS: STREET 1: 10421 PACIFIC CENTER COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-362-6295 MAIL ADDRESS: STREET 1: 10421 PACIFIC CENTER COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: ANAPTYSBIO INC DATE OF NAME CHANGE: 20080828 FORMER COMPANY: FORMER CONFORMED NAME: ANAPTYS BIOSCIENCES INC DATE OF NAME CHANGE: 20060724 8-K 1 anab3920208k.htm 8-K Document
false0001370053 0001370053 2020-03-06 2020-03-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: March 6, 2020
(Date of earliest event reported)

ANAPTYSBIO, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
001-37985
20-3828755
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
            
10421 Pacific Center Court, Suite 200
San Diego, CA 92121
(Address of Principal Executive Offices, and Zip Code)

(858) 362-6295
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a‑12 under the Exchange Act (17 CFR 240.14a‑12)
Pre‑commencement communications pursuant to Rule 14d‑2(b) under the Exchange Act (17 CFR 240.14d‑2(b))
Pre‑commencement communications pursuant to Rule 13e‑4(c) under the Exchange Act (17 CFR 240.13e‑4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.
Departure of Directors or Certain Officers; Election Of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 6, 2020, AnaptysBio, Inc. (“AnaptysBio”) mutually agreed with Marco Londei, the Chief Medical Officer of AnaptysBio, to end his employment effective March 25, 2020. AnaptysBio has initiated recruitment of a new Chief Medical Officer to lead development of AnaptysBio’s clinical product pipeline. In the interim, J. Anthony Ware, MD, who joined the Board of Directors of AnaptysBio in August 2017, and previously served as Senior Vice President of Product Development at Eli Lilly and Company, will be providing additional oversight to AnaptysBio’s clinical and regulatory functions.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                   
 
AnaptysBio, Inc.
Date: March 9, 2020
By:
/s/ Hamza Suria
 
 
Name: Hamza Suria
 
 
Title: Chief Executive Officer



 
EX-101.SCH 2 anab-20200306.xsd EXHIBIT 101.SCH 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 anab-20200306_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 anab-20200306_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 anab-20200306_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 6 anab-20200306_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 anab3920208k_htm.xml IDEA: XBRL DOCUMENT 0001370053 2020-03-06 2020-03-06 false 0001370053 8-K 2020-03-06 ANAPTYSBIO, INC DE 001-37985 20-3828755 10421 Pacific Center Court Suite 200 San Diego CA 92121 858 362-6295 false false false false Common Stock, par value $0.001 per share ANAB NASDAQ false XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end ZIP 12 0001370053-20-000013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001370053-20-000013-xbrl.zip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end JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "anab3920208k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "anab-20200306_cal.xml" ] }, "definitionLink": { "local": [ "anab-20200306_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "anab3920208k.htm" ] }, "labelLink": { "local": [ "anab-20200306_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "anab-20200306_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "anab-20200306.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "anab", "nsuri": "http://www.anaptysbio.com/20200306", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "anab3920208k.htm", "contextRef": "D2020Q1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.anaptysbio.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "anab3920208k.htm", "contextRef": "D2020Q1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.anaptysbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.anaptysbio.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports anab3920208k.htm anab-20200306.xsd anab-20200306_cal.xml anab-20200306_def.xml anab-20200306_lab.xml anab-20200306_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
Mar. 06, 2020
Cover page.  
Document Type 8-K
Document Period End Date Mar. 06, 2020
Entity Registrant Name ANAPTYSBIO, INC
Entity Incorporation, State or Country Code DE
Entity File Number 001-37985
Entity Tax Identification Number 20-3828755
Entity Address, Address Line One 10421 Pacific Center Court
Entity Address, Address Line Two Suite 200
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 362-6295
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ANAB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001370053
Amendment Flag false